Moreover, Hsp90 is involved in the stabilization of oncogenic proteins (e.g., Bcr-Abl, HER-2, EGFR, and HIF-1α); hence, the inhibitors of its chaperone activity are currently being tested as cancer treatment in advanced clinical trials [14,15]. Here, HSP90AB1 is linked to cancer.